Bipolar Disorder

Bipolar disorder, or manic-depressive disorder, is a mood disorder that causes radical emotional changes and mood swings, from manic highs to depressive lows. The majority of bipolar individuals experience alternating episodes of mania and depression.

Bipolar Disorder - most related articles:

- Study to pinpoint bipolar disorder risk factors - 9.7
- Bipolar symptoms and emotional brain in youth - 9.2
- Complete Response Letter on Seroquel XR for major depressive disorder - 8.5
- Role of Omega-3 unclear for bipolar disorder - 8
- Risperdal Consta approved for bipolar disorder - 7
- Bright light therapy eases bipolar depression - 6.3
- Schizophrenia linked to common genetic variations - 4.1
- Eli Lilly denied NYT report of schizophrenia drug Zyprexa - 3.8
- RISPERDAL and Risperidone Tablets recalled due to odor of TBA - 3.7
- 14 drugs identified for off label use - 3

Bipolar Disorder articles

Bipolar symptoms and emotional brain in youth
Recognition of bipolar symptoms and bipolar disorder in adolescents is now clearly established. However, whether bipolarity exists in children remains controversial despite numerous studies that have been conducted on this topic in the last fifteen years.

Lithium may prevent brain damage in patients with Parkinson's disease
Researcher are focusing on lithium as a potential treatment for Parkinson's disease -- PD -- as well as its efficacy in combination with drugs currently used to control the symptoms of the disease. Lithium profoundly prevents the aggregation of toxic proteins and cell loss associated with Parkinson's disease (PD) in a mouse model of the condition.

RISPERDAL and Risperidone Tablets recalled due to odor of TBA
Ortho-McNeil-Janssen Pharmaceuticals, Inc. is initiating a voluntary recall of one lot of RISPERDAL® (risperidone) 3mg Tablets, marketed by Janssen Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. and one lot of risperidone 2mg Tablets, marketed by Patriot Pharmaceuticals, LLC, a wholly owned subsidiary of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Anticonvulsant medications linked to increased risk of suicide
An analysis of prescription and clinical claims data suggests that the use of certain anticonvulsant medications may be associated with an increased risk of suicide, attempted suicide or violent death, according to a study in the April 14 issue of JAMA.

Study to pinpoint bipolar disorder risk factors
Around 500 Australians aged 12 to 30 will be recruited to take part in a new study to know causes of bipolar disorder and related risk factors, to be conducted in collaboration with four major research institutions in the United States - Johns Hopkins University in Baltimore and the Universities of Michigan, Indiana and Washington.

Schizophrenia linked to common genetic variations
Researchers has discovered that nearly a third of the genetic basis of schizophrenia may be attributed to the cumulative actions of thousands of common genetic variants.

Risperdal Consta approved for bipolar disorder
Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) has approved the Supplemental New Drug Applications (sNDAs) for the use of RISPERDAL® CONSTA® (risperidone) Long-Acting Treatment as both monotherapy and adjunctive therapy to lithium or valproate in the maintenance treatment of Bipolar I Disorder.

Epilepsy drug valproate during pregnancy lowers child's IQ
Three-year-olds whose mothers took the antiepileptic drug valproate during pregnancy had average IQs six to nine points lower than children exposed to three other antiepileptic drugs, a landmark multi-center study has found.

Complete Response Letter on Seroquel XR for major depressive disorder
AstraZeneca announced the company has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) asking for additional information for the supplemental New Drug Application for SEROQUEL XR (quetiapine fumarate) Extended Release Tablets for the treatment of Major Depressive Disorder (MDD) in adult patients.

14 drugs identified for off label use
Physicians and policy-makers know that drugs are frequently prescribed to treat certain diseases despite a lack of FDA approval - a practice known as off-label prescribing. Yet they say the problem is so big they don't know how to begin tackling it.

Role of Omega-3 unclear for bipolar disorder
Despite intriguing findings that omega-3 fatty acid supplements could alleviate depression symptoms, there is still not enough evidence to say whether omega-3s are useful treatments for people with bipolar disorder, according to a review of recent studies.

Eli Lilly denied NYT report of schizophrenia drug Zyprexa
Eli Lilly and Company (NYSE: LLY) called the assertions in a New York Times online article 'flat out wrong.' A report in The New York Times that said a senior executive had encouraged the promotion of its schizophrenia drug Zyprexa for a use not approved by federal regulators.

Suicidal thoughts and behaviours from epilepsy drugs, alerts Medsafe
Medsafe, New Zealand's Ministry of Health's medicines regulatory arm, is alerting health care professionals in New Zealand about a small increased risk of suicidal thoughts and behaviours in patients taking anti-epileptic medicines.

Epilepsy drugs may raise suicide risk, warns FDA
An increased risk of suicidal thoughts and behaviors (suicidality) in patients who take drugs called antiepileptics to treat epilepsy, bipolar disorder, migraine headaches, and other conditions, reported by U.S. Food and Drug Administration (FDA).

Bright light therapy eases bipolar depression
Bright light therapy can ease bipolar depression in some patients, according to a study published in the journal Bipolar Disorders. Researchers from the University of Pittsburgh School of Medicine's Western Psychiatric Institute and Clinic studied nine women with bipolar disorder to examine the effects of light therapy in the morning or at midday on mood symptoms.

15 Bipolar Disorder articles listed above.

What is Bipolar Disorder
Bipolar disorder, or manic-depressive disorder, is a mood disorder that causes radical emotional changes and mood swings, from manic highs to depressive lows. The majority of bipolar individuals experience alternating episodes of mania and depression.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
7.16